The Burden of Stroke Report, performed by King’s College London on behalf of SAFE in May 2017 is now translated to Spanish and Italian language. We would like to thank our partner Bristol-Myers Squibb (BMS), a part of a BMS-Pfizer Alliance for their support in obtaining the Spanish version and we express our gratitude to organisations ARS Umbria and ALICe Italia for their support in translating this report to Italian language.
Please see below the front covers of both reports. You can download the Italian version by clicking on the picture and Spanish version will be launched soon. Stay tuned!
Patients with congenital heart disease are up to 85 times more likely to suffer from atrial fibrillation as adults. The researchers behind a study, published in the journal Circulation, are now advocating more frequent screenings of the most vulnerable groups.
“We need to identify those who have the most increased risk of complications. Today they are young adults and we are not sure what will happen once they get into their 50’s or 60’s,” says Zacharias Mandalenakis, cardiology researcher at Sahlgrenska Academy, Sweden, and cardiology consultant at Sahlgrenska university hospital. (more…)
Scientists in Finland have shown that sauna bathing is associated with a variety of health benefits. Using an experimental setting this time, the research group now investigated the physiological mechanisms through which the heat exposure of sauna may influence a person’s health. Their latest study with 100 test subjects shows that taking a sauna bath of 30 minutes reduces blood pressure and increases vascular compliance, while also increasing heart rate similarly to medium-intensity exercise. (more…)
In just four months, high-doses of vitamin D reduce arterial stiffness in young, overweight/obese, vitamin-deficient, but otherwise still healthy African-Americans, researchers say.
Rigid artery walls are an independent predictor of cardiovascular- related disease and death and vitamin D deficiency appears to be a contributor, says Dr. Yanbin Dong, geneticist and cardiologist at the Georgia Prevention Institute at the Medical College of Georgia at Augusta University. (more…)
Despite decades long prevention and treatment efforts, cardiovascular (CV) disease continues to be the leading cause of death worldwide. Early detection of CV disease can allow for interventions to prevent heart attack and stroke, including smoking cessation, medications such as a statins, blood pressure control, weight management, exercise, and improved diet. A new study published online first today in the journal Vascular Medicine, focuses on a novel risk factor for cardiovascular disease that rarely receives attention — erectile dysfunction. (more…)
Varenicline, one of the most commonly prescribed drugs for helping people quit smoking, may put them at higher risk for a cardiovascular event, according to new research published online in the American Journal of Respiratory and Critical Care Medicine.
In “Cardiovascular and Neuropsychiatric Events Following Varenicline Use for Smoking Cessation,” researchers in Canada report that in an observational, self-controlled trial, patients prescribed varenicline (Chantix in the U.S.; Champix in Canada and Europe) were 34 percent more likely to have an emergency department visit or hospitalization for a cardiovascular event while taking the drug. Among those patients who had not previously experienced a cardiovascular event, the increased incidence was only 12 percent. (more…)